Alterations to the broad-spectrum formin inhibitor SMIFH2 improve potency
Orman, M.; Landis, M.; Oza, A.; Nambiar, D.; Gjeci, J.; Song, K.; Huang, V.; Klestzick, A.; Hachicho, C.; Liu, S. Q.; Kamm, J. M.; Bartolini, F.; Vadakkan, J. J.; Rojas, C. M.; Vizcarra, C. L.
Show abstract
SMIFH2 is a small molecule inhibitor of the formin family of cytoskeletal regulators that was originally identified in a screen for suppression of actin polymerization induced by the mouse formin Diaphanous 1 (mDia1). Despite widespread use of this compound, it is unknown whether SMIFH2 inhibits all human formins. Additionally, the nature of protein/inhibitor interactions remains elusive. We assayed SMIFH2 against human formins representing six of the seven mammalian classes and found inhibitory activity against all formins tested. We synthesized a panel of SMIFH2 derivatives and found that, while many alterations disrupt SMIFH2 activity, substitution of an electron-donating methoxy group in place of the bromine along with halogenation of the furan ring increases potency by approximately five-fold. Similar to SMIFH2, the active derivatives are also pan-inhibitors for the formins tested. This result suggests that while potency can be improved, the goal of distinguishing between highly conserved FH2 domains may not be achievable using the SMIFH2 scaffold.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structure and Mechanism of Avermitilol Synthase, a Sesquiterpene Cyclase that Generates a Highly Strained 6-6-3 Tricyclic Alcohol 95%
- Mechanism Underlying Anti-Markovnikov Addition in the Reaction of Pentalenene Synthase 95%
- Nanomolar, noncovalent antagonism of hedgehog cholesterolysis: exception to the irreversibility rule for protein autoprocessing inhibition. 95%
Similar papers in this journal
- Repurposing of the RIPK1 selective benzooxazepin-4-one scaffold for the development of a type-III LIMK1/2 inhibitor 95%
- Expanding the substrate selectivity of the fimsbactin biosynthetic adenylation domain, FbsH 95%
- Integrative x-ray structure and molecular modeling for the rationalization of procaspase-8 inhibitor potency and selectivity 95%
Similar papers in this journal
- TRPM8 protein dynamics correlates with ligand structure and cellular function 95%
- Semi-synthetic CoA-alpha-Synuclein Constructs Trap N-terminal Acetyltransferase NatB for Binding Mechanism Studies 95%
- Bioluminescence Imaging of Potassium Ion Using a Sensory Luciferin and an Engineered Luciferase 94%
Similar papers in this journal
- Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease. 96%
- Development of a novel high-throughput screen for the identification of new inhibitors of protein S-acylation 96%
- Crystal Structure of Histone Deacetylase 6 Complexed with (R)-Lipoic Acid, an Essential Cofactor in Central Carbon Metabolism 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.